| CELGENE CORP. DL-,01 | 97.370 |
| Date/Time | 11/20 / 19:44 |
| Chg. / Chg.(%) | - / |
| Bid | - |
| Ask | - |
| Open | 97.370 |
| Previous Close | 97.370 |
| High | 97.840 |
| Low | 96.550 |
| Volume [EUR] | - |
| Volume [Units] | |
| Price fixings | 14756 |
| ISIN | US1510201049 |
| Security | CG3 |
| Exchange | Lang & Schwarz |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| SIX Swiss Ex.. | 91.90 | ||
| SIX Swiss Ex.. | 89.40 | ||
| NASDAQ | 108.2400 | 191,230,586 | |
| Cboe US | 108.28 | 4,250,731 | |
| IEX | 108.30 | 1,222,357 | |
| London Inter.. | 107.94 | 826,453 | |
| Stuttgart | 97.500 | 563 | |
| Mexico | 2,099.33 | 532 | |
| gettex | 97.400 | 110 | |
| Lang & Schwa.. | 97.370 |
News
- BeiGene Announces Clinical Data on BRUKINSA™ (Zanubrutinib) at the 61st American Society of Hematology (ASH) Annual Meeting
12/08/2019 / 22:45 - GlobeNewswire - Prothena Announces Appointment of Oleg Nodelman to its Board of Directors
12/05/2019 / 22:05 - GlobeNewswire - BeiGene to Present at the 31st Annual Piper Jaffray Healthcare Conference
11/26/2019 / 13:00 - GlobeNewswire - Agios Appoints Jonathan Biller as Chief Legal Officer
11/25/2019 / 13:00 - GlobeNewswire - BeiGene Announces Clinical Data on Tislelizumab Presented at European Society for Medical Oncology (ESMO) Asia 2019 Congress
11/23/2019 / 11:00 - GlobeNewswire
Real-time